Paul J. Hesketh
Caritas St. Elizabeth's Medical Center of Boston
Boston
Massachusetts 02135
USA
Name/email consistency: high
- Chemotherapy-induced nausea and vomiting. Hesketh, P.J. N. Engl. J. Med. (2008)
- Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide. Hesketh, P.J., Younger, J., Sanz-Altamira, P., Hayden, M., Bushey, J., Trainor, B., Krentzin, M., Nowd, P., Arnaoutakis, K., Hesketh, A.M. Support. Care. Cancer (2008)
- Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718. Hesketh, P.J., Chansky, K., Israel, V., Grapski, R.T., Mekhail, T.M., Spiridonidis, C.H., Mills, G.M., Kelly, K., Crowley, J.J., Gandara, D.R. J. Thorac. Oncol (2007)
- Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6. Hesketh, P.J., Lilenbaum, R.C., Chansky, K., Dowlati, A., Graham, P., Chapman, R.A., Crowley, J.J., Gandara, D.R. J. Thorac. Oncol (2007)
- Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914. Hesketh, P.J., McCoy, J., Dunphy, F.R., Bearden, J.D., Weiss, G.R., Giguere, J.K., Atkins, J.N., Dakhil, S.R., Kelly, K., Crowley, J.J., Gandara, D.R. J. Thorac. Oncol (2006)
- Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response. Hesketh, P.J., Grunberg, S.M., Herrstedt, J., de Wit, R., Gralla, R.J., Carides, A.D., Taylor, A., Evans, J.K., Horgan, K.J. Support. Care. Cancer (2006)
- A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies. Hesketh, P.J., Arena, F., Patel, D., Austin, M., D'Avirro, P., Rossi, G., Colowick, A., Schwartzberg, L., Bertoli, L.F., Cole, J.T., Demetri, G., Dessypris, E., Dobbs, T., Eisenberg, P., Fleischman, R., Hall, J., Hoffman, P.C., Laber, D.A., Leonard, J., Lester, E.P., McCachren, S., McMeekin, S., Meza, L., Miller, D.S., Nand, S., Oliff, I., Paroly, W., Pawl, L., Perez, A., Raftopoulos, H., Rigas, J., Rowland, K., Scullin, D.C., Tezcan, H., Waples, J., Ward, J., Yee, L.K. Cancer (2004)
- Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Hesketh, P.J., Batchelor, D., Golant, M., Lyman, G.H., Rhodes, N., Yardley, D. Support. Care. Cancer (2004)
- New treatment options for chemotherapy-induced nausea and vomiting. Hesketh, P.J. Support. Care. Cancer (2004)
- The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group. Hesketh, P.J., Grunberg, S.M., Gralla, R.J., Warr, D.G., Roila, F., de Wit, R., Chawla, S.P., Carides, A.D., Ianus, J., Elmer, M.E., Evans, J.K., Beck, K., Reines, S., Horgan, K.J. J. Clin. Oncol. (2003)
- Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancer. Hesketh, P.J., Nauman, C.J., Hesketh, A.M., LaPointe, J., Fogarty, K., Oo, T.H., Lau, D.H., Edelman, M.J., Gandara, D.R. Clin. Lung. Cancer (2002)
